Luis E. Rodrı́guez

Author

Luis E. Rodrı́guez

Also Known As

L E Rodriguez, L Rodriguez, L. E. RODRIGUEZ, L. Rodriguez, L.E Rodriguez, L.E. Rodriguez, LUIS E. RODRIGUEZ, Luis E Rodriguez, Luis E Rodrı́guez, Luis E. Rodriguez

Publications

Citations

H-Index

Concepts

All Affiliations

Universidad Nacional de Colombia Fundación Instituto de Inmunología de Colombia Abbott Fund AbbVie (United States)Hospital Universitario Nacional de Colombia

About

Luis E. Rodrı́guez is an author at Universidad Nacional de Colombia specializing in medicine, natural sciences, and proteomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	32	1.1K
2	Natural Sciences	17	24	745
3	Biochemistry	14	18	585
4	Health Sciences	1	1	100
5	Public Health	1	1	15

Luis E. Rodrı́guez

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models Cherrie K. Donawho, Yan Luo, Yanping Luo, Clinical Cancer Research	2007	762
Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez, Molecular Cancer Research	2015	257
ABT-888 Confers Broad <i>In vivo</i> Activity in Combination with Temozolomide in Diverse Tumors Joann P. Palma, Yichun Wang, Luis E. Rodrı́guez, Clinical Cancer Research	2009	138
Identification of Plasmodium falciparum MSP‐1 peptides able to bind to human red blood cells Mauricio Urquiza, Luis E. Rodrı́guez, Jorge E. Suarez, Parasite Immunology	1996	128
Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents Yunsong Tong, Jennifer J. Bouska, Eric F. Johnson, Journal of Medicinal Chemistry Small Molecule InhibitorsPharmaceutical ScienceBioorganic ChemistryNew GenerationPharmacotherapy	2009	108
Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1<i>H</i>-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model Tricia J. Vos, Andrei Caracoti, L. McGlothan Jennifer, Journal of Medicinal Chemistry Food IntakeTumor BiologyGastrointestinal Peptide HormoneTranslational PharmacologyObesity	2004	100
<i>Plasmodium falciparum</i> EBA-175 kDa protein peptides which bind to human red blood cells Luis E. Rodrı́guez, Mauricio Urquiza, Marisol Ocampo, Parasitology	2000	87
Potentiation of Temozolomide Cytotoxicity by Poly(ADP)Ribose Polymerase Inhibitor ABT-888 Requires a Conversion of Single-Stranded DNA Damages to Double-Stranded DNA Breaks Xuesong Liu, Yan Shi, Ran Guan, Molecular Cancer Research Dna DamageApoptosisSingle-stranded Dna DamagesMolecular BiologyCell Death	2008	76
Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (<i>S</i>)-2-(2-Fluoro-4-(pyrrolidin-2-yl)phenyl)-1<i>H</i>-benzimidazole-4-carboxamide (A-966492), a Highly Potent and Efficacious Inhibitor T.M. Penning, Gui‐Dong Zhu, Jianchun Gong, Journal of Medicinal Chemistry Excellent PotencyPharmaceutical SciencePharmacotherapyChemical BiologyPharmaceutical Chemistry	2010	70
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes Luis E. Rodrı́guez, Mauricio Urquiza, Marisol Ocampo, Vaccine Protein FunctionNatural SciencesMedicineMsp-1 PeptidesImmunology	2002	59

Page 1